Published in J Clin Invest on November 01, 1989
Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol (1995) 10.61
The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell (1993) 4.33
Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci U S A (1991) 3.95
Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med (1990) 3.93
A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells. EMBO J (2001) 3.92
Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol (1994) 3.76
Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci U S A (1997) 3.30
Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest (1994) 3.11
Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med (1994) 3.09
Phase I study of intravenous vascular endothelial growth factor trap, aflibercept, in patients with advanced solid tumors. J Clin Oncol (2009) 2.97
Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. Proc Natl Acad Sci U S A (1995) 2.94
Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol (1993) 2.85
Src-mediated coupling of focal adhesion kinase to integrin alpha(v)beta5 in vascular endothelial growth factor signaling. J Cell Biol (2002) 2.84
Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. Am J Pathol (1997) 2.73
The role of vascular endothelial growth factor in wound healing. J Surg Res (2008) 2.68
Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin. Am J Pathol (1996) 2.42
Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Invest (1993) 2.42
Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci U S A (1993) 2.32
Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J Clin Invest (1994) 2.30
Tumor-secreted vascular permeability factor increases cytosolic Ca2+ and von Willebrand factor release in human endothelial cells. Am J Pathol (1991) 2.26
Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J Clin Invest (1993) 2.07
Control of hair growth and follicle size by VEGF-mediated angiogenesis. J Clin Invest (2001) 2.04
Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. Proc Natl Acad Sci U S A (1995) 1.98
Rous-Whipple Award Lecture. How tumors make bad blood vessels and stroma. Am J Pathol (2003) 1.95
Vascularity in asthmatic airways: relation to inhaled steroid dose. Thorax (1999) 1.94
Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralization. Am J Pathol (1998) 1.90
Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma. Br J Cancer (1996) 1.84
Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J Clin Invest (1996) 1.82
The regulation of vascular endothelial growth factor-induced microvascular permeability requires Rac and reactive oxygen species. J Biol Chem (2009) 1.69
Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications. Ann Rheum Dis (1992) 1.65
The role of VEGF receptors in angiogenesis; complex partnerships. Cell Mol Life Sci (2006) 1.63
Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. Am J Pathol (1998) 1.61
Topical bevacizumab in the treatment of corneal neovascularization: results of a prospective, open-label, noncomparative study. Arch Ophthalmol (2009) 1.60
Leukemia regression by vascular disruption and antiangiogenic therapy. Blood (2010) 1.60
Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts. J Clin Invest (1994) 1.57
Adipose stem cells can secrete angiogenic factors that inhibit hyaline cartilage regeneration. Stem Cell Res Ther (2012) 1.56
Vascular endothelial cell growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites. Proc Natl Acad Sci U S A (1991) 1.55
Regulation of scar formation by vascular endothelial growth factor. Lab Invest (2008) 1.51
Roles for VEGF in the adult. Microvasc Res (2007) 1.48
Inhibition of tumor growth, angiogenesis, and microcirculation by the novel Flk-1 inhibitor SU5416 as assessed by intravital multi-fluorescence videomicroscopy. Neoplasia (1999) 1.47
Vascular endothelial growth factor expression in choroidal neovascularization in rats. Graefes Arch Clin Exp Ophthalmol (1997) 1.44
Encapsulating peritoneal sclerosis: the state of affairs. Nat Rev Nephrol (2011) 1.44
Expression of vascular endothelial growth factor induces an invasive phenotype in human squamous cell carcinomas. Am J Pathol (2000) 1.44
Involvement of the transcription factor NF-kappaB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress. Mol Cell Biol (1996) 1.42
Expression of vascular endothelial growth factor does not promote transformation but confers a growth advantage in vivo to Chinese hamster ovary cells. J Clin Invest (1993) 1.42
Identification of a human VPF/VEGF 3' untranslated region mediating hypoxia-induced mRNA stability. Mol Biol Cell (1998) 1.40
Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer. Mol Cancer (2003) 1.39
Adeno-associated viral vector-mediated hypoxia response element-regulated gene expression in mouse ischemic heart model. Proc Natl Acad Sci U S A (2002) 1.37
The role of inflammatory mediators in the pathogenesis of otitis media and sequelae. Clin Exp Otorhinolaryngol (2008) 1.36
Patterns of brain angiogenesis after vascular endothelial growth factor administration in vitro and in vivo. Proc Natl Acad Sci U S A (1998) 1.33
Diffuse EGFR staining is associated with reduced overall survival in locally advanced oesophageal squamous cell cancer. Br J Cancer (2005) 1.31
Microenvironment and pathogenesis of epithelial ovarian cancer. Horm Cancer (2010) 1.30
Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma. Am J Pathol (1996) 1.30
Regulation of microvascular permeability by vascular endothelial growth factors. J Anat (2002) 1.30
Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy. Br J Ophthalmol (1996) 1.29
Role of vascular permeability factor/vascular endothelial growth factor in eye disease. Br J Ophthalmol (1997) 1.29
Fibrin gel-immobilized VEGF and bFGF efficiently stimulate angiogenesis in the AV loop model. Mol Med (2007) 1.27
Characterization of the increase in vascular permeability induced by vascular permeability factor in vivo. Br J Pharmacol (1993) 1.26
Molecular framework for angiogenesis: a complex web of interactions between extravasated plasma proteins and endothelial cell proteins induced by angiogenic cytokines. Am J Pathol (1996) 1.26
Identification of the antivasopermeability effect of pigment epithelium-derived factor and its active site. Proc Natl Acad Sci U S A (2004) 1.26
Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas. Am J Pathol (1996) 1.25
Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor. Rheumatology (Oxford) (2009) 1.24
Critical appraisal of ranibizumab in the treatment of diabetic macular edema. Clin Ophthalmol (2013) 1.23
Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants. Br J Pharmacol (2000) 1.23
Src kinase becomes preferentially associated with the VEGFR, KDR/Flk-1, following VEGF stimulation of vascular endothelial cells. BMC Biochem (2002) 1.23
Angiogenesis in epithelian ovarian cancer. Mol Pathol (2002) 1.21
Regulation of VEGF mRNA expression and protein secretion by TGF-beta2 in human retinal pigment epithelial cells. Exp Eye Res (2007) 1.20
The role of the vascular phase in solid tumor growth: a historical review. Neoplasia (1999) 1.20
Hypoxia augments cytokine (transforming growth factor-beta (TGF-beta) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts. Clin Exp Immunol (1999) 1.19
Bevacizumab as a treatment for radiation necrosis of brain metastases post stereotactic radiosurgery. Neuro Oncol (2013) 1.18
Immediate and delayed VEGF-mediated NO synthesis in endothelial cells: role of PI3K, PKC and PLC pathways. Br J Pharmacol (2002) 1.17
Placenta growth factor (PlGF) induces vascular endothelial growth factor (VEGF) secretion from mononuclear cells and is co-expressed with VEGF in synovial fluid. Clin Exp Immunol (2000) 1.16
Angiogenesis in the pathogenesis of inflammatory joint and lung diseases. Arthritis Res (2001) 1.15
Blood-ocular barrier breakdown in eyes with ocular melanoma. A potential role for vascular endothelial growth factor/vascular permeability factor. Am J Pathol (1995) 1.13
Murine neural stem/progenitor cells protect neurons against ischemia by HIF-1alpha-regulated VEGF signaling. PLoS One (2010) 1.12
Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: where do we stand? Front Neurosci (2010) 1.12
Regulation of angiogenesis during osseointegration by titanium surface microstructure and energy. Biomaterials (2010) 1.11
Thrombospondin 2 expression is correlated with inhibition of angiogenesis and metastasis of colon cancer. Br J Cancer (1999) 1.09
Role of lysophosphatidylcholine in the inhibition of endothelial cell motility by oxidized low density lipoprotein. J Clin Invest (1996) 1.09
Oxidized low density lipoprotein inhibits the migration of aortic endothelial cells in vitro. J Cell Biol (1993) 1.09
VEGF enhances intraneural angiogenesis and improves nerve regeneration after axotomy. J Anat (2000) 1.09
Intracrine vascular endothelial growth factor signaling in survival and chemoresistance of human colorectal cancer cells. Oncogene (2010) 1.08
Stimulation by thyroid-stimulating hormone and Grave's immunoglobulin G of vascular endothelial growth factor mRNA expression in human thyroid follicles in vitro and flt mRNA expression in the rat thyroid in vivo. J Clin Invest (1995) 1.08
Effects of ginseng saponins isolated from Red Ginseng roots on burn wound healing in mice. Br J Pharmacol (2006) 1.07
Unexpected benefits of intermittent hypoxia: enhanced respiratory and nonrespiratory motor function. Physiology (Bethesda) (2014) 1.07
The aortic ring model of angiogenesis: a quarter century of search and discovery. J Cell Mol Med (2009) 1.07
Spinal vascular endothelial growth factor induces phrenic motor facilitation via extracellular signal-regulated kinase and Akt signaling. J Neurosci (2011) 1.07
Specific roles for the PI3K and the MEK-ERK pathway in IGF-1-stimulated chemotaxis, VEGF secretion and proliferation of multiple myeloma cells: study in the 5T33MM model. Br J Cancer (2004) 1.07
Human embryonic stem cell-derived mesenchymal stromal cell transplantation in a rat hind limb injury model. Cytotherapy (2009) 1.05
Tumors: wounds that do not heal-redux. Cancer Immunol Res (2015) 1.05
Tumor angiogenesis: insights and innovations. J Oncol (2010) 1.04
Regulation of the endogenous VEGF-A gene by exogenous designed regulatory proteins. Proc Natl Acad Sci U S A (2004) 1.04
Helicobacter pylori promote gastric cancer cells invasion through a NF-kappaB and COX-2-mediated pathway. World J Gastroenterol (2005) 1.03
Downregulation of vascular endothelial growth factor receptors by tumor necrosis factor-alpha in cultured human vascular endothelial cells. J Clin Invest (1996) 1.03
Vascular endothelial growth factor-A stimulates Snail expression in breast tumor cells: implications for tumor progression. Exp Cell Res (2008) 1.03
Significance of vascular endothelial growth factor messenger RNA expression in gastric cancer. World J Gastroenterol (1998) 1.03
VEGF induces cardiovascular malformation and embryonic lethality. Am J Pathol (1997) 1.03
Tumor-immune interaction, surgical treatment, and cancer recurrence in a mathematical model of melanoma. PLoS Comput Biol (2009) 1.02
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity. Anal Biochem (1981) 29.21
The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. Biochem J (1973) 22.93
Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science (1983) 15.43
Angiogenic factors. Science (1987) 15.22
Vascular reactions to histamine, histamine-liberator and leukotaxine in the skin of guinea-pigs. J Physiol (1952) 13.84
Epidermal growth factor. Annu Rev Biochem (1979) 11.82
Culture of vascular endothelium. Prog Hemost Thromb (1976) 7.05
Tumor angiogenesis. Adv Cancer Res (1985) 5.66
Isolation of brain fibroblast growth factor by heparin-Sepharose affinity chromatography: identity with pituitary fibroblast growth factor. Proc Natl Acad Sci U S A (1984) 4.41
A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res (1986) 4.12
Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature (1989) 3.80
Microvascular permeability of normal and neoplastic tissues. Microvasc Res (1986) 3.04
Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin 2. J Immunol (1986) 2.82
Human tumor cells synthesize an endothelial cell growth factor that is structurally related to basic fibroblast growth factor. Proc Natl Acad Sci U S A (1986) 2.55
Purification and characterization of acidic fibroblast growth factor from bovine brain. Proc Natl Acad Sci U S A (1984) 2.47
Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing. Lab Invest (1987) 2.20
Unique structure of murine interleukin-2 as deduced from cloned cDNAs. Nature (1985) 2.15
Identification of the fibroblast growth factor receptor of Swiss 3T3 cells and mouse skeletal muscle myoblasts. Biochemistry (1986) 2.06
Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages. Lab Invest (1984) 2.04
Determination of the number of endothelial cells in culture using an acid phosphatase assay. Anal Biochem (1986) 1.71
Endothelial proliferation in the delayed hypersensitivity reaction: an autoradiographic study. J Immunol (1977) 1.67
Isolation of pituitary fibroblast growth factor by fast protein liquid chromatography (FPLC): partial chemical and biological characterization. J Cell Physiol (1985) 1.41
Quantitative study of vascularity in Walker carcinoma 256. Cancer Res (1971) 1.35
Accessibility of circulating immunoglobulin G to the extravascular compartment of solid rat tumors. Cancer Res (1984) 1.33
Fibrinogen influx and accumulation of cross-linked fibrin in mouse carcinomas. Cancer Res (1988) 1.23
An assay measuring the stimulation of several types of bovine endothelial cells by growth factor(s) derived from cultured human tumor cells. In Vitro (1982) 1.13
Culture of human endothelial cells. Transplant Proc (1980) 1.11
Optimized medium for clonal growth of human microvascular endothelial cells with minimal serum. In Vitro Cell Dev Biol (1987) 1.10
Isolation, growth requirements, cloning, prostacyclin production and life-span of human adult endothelial cells in low serum culture medium. In Vitro Cell Dev Biol (1986) 1.07
Enhancement of angiogenesis by bFGF in mandibular bone graft healing in the rabbit. J Oral Maxillofac Surg (1988) 1.00
Increase of rat pulmonary microvascular permeability to albumin by recombinant interleukin-2. Cancer Res (1987) 0.99
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol (1997) 29.02
Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science (1989) 8.10
Crow deaths as a sentinel surveillance system for West Nile virus in the northeastern United States, 1999. Emerg Infect Dis (2001) 5.83
A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res (1986) 4.12
Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med (1990) 3.93
Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. Cancer Res (1990) 3.35
Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ (1989) 3.32
Attenuation of isoproterenol-mediated vasodilatation in blacks. N Engl J Med (1995) 3.25
The determination of the concentration of hydrolytic enzyme solutions: alpha-chymotrypsin, trypsin, papain, elastase, subtilisin, and acetylcholinesterase. J Am Chem Soc (1966) 3.09
Multiple DNA fragment polymorphisms associated with immunoglobulin mu chain switch-like regions in man. Proc Natl Acad Sci U S A (1983) 3.07
Engineering herbicide tolerance in transgenic plants. Science (1986) 3.07
A full genome search in multiple sclerosis. Nat Genet (1996) 2.96
Comparison of uninsured and privately insured hospital patients. Condition on admission, resource use, and outcome. JAMA (1991) 2.80
Bcl-2 family proteins are essential for platelet survival. Cell Death Differ (2007) 2.67
Cartilage-inducing factor-A. Apparent identity to transforming growth factor-beta. J Biol Chem (1986) 2.61
The evolution of Titan's mid-latitude clouds. Science (2005) 2.46
Ectopic induction of tendon and ligament in rats by growth and differentiation factors 5, 6, and 7, members of the TGF-beta gene family. J Clin Invest (1997) 2.42
Intestinal permeability in children with Crohn's disease and coeliac disease. Br Med J (Clin Res Ed) (1982) 2.36
Virus-specific IgG and IgM antibodies in normal and immunocompromised subjects infected with cytomegalovirus. J Infect Dis (1982) 2.29
West Nile virus surveillance in Connecticut in 2000: an intense epizootic without high risk for severe human disease. Emerg Infect Dis (2001) 2.26
Quantitative studies of in vitro transformation by chemical carcinogens. J Natl Cancer Inst (1969) 2.26
Intracellular staining reveals different levels of stratification for on- and off-center ganglion cells in cat retina. J Neurophysiol (1978) 2.19
Induction of a fibrin-gel investment: an early event in line 10 hepatocarcinoma growth mediated by tumor-secreted products. J Immunol (1979) 2.15
Conservation. High value and long life--double jeopardy for tunas and billfishes. Science (2011) 2.14
Human vascular permeability factor. Isolation from U937 cells. J Biol Chem (1989) 2.12
The Abbott IMx automated benchtop immunochemistry analyzer system. Clin Chem (1988) 2.12
Space flight alters bacterial gene expression and virulence and reveals a role for global regulator Hfq. Proc Natl Acad Sci U S A (2007) 2.05
How did Medicare's prospective payment system affect hospitals? N Engl J Med (1987) 2.05
Differential HFE allele expression in hemochromatosis heterozygotes. Gastroenterology (2000) 2.04
Intestinal permeability in the newborn. Arch Dis Child (1984) 1.94
Profits and fiscal pressure in the prospective payment system: their impacts on hospitals. Inquiry (1989) 1.85
Purification and sequence analysis of bioactive atrial peptides (atriopeptins). Science (1984) 1.85
Cat cones have rod input: a comparison of the response properties of cones and horizontal cell bodies in the retina of the cat. J Comp Neurol (1977) 1.84
Cystic fibrosis and coeliac disease: coexistence in two children. Arch Dis Child (1973) 1.80
Effect of ambient temperature storage on potable water coliform population estimations. Appl Environ Microbiol (1983) 1.79
Identification of cross-reactive antibodies with low opsonophagocytic activity for Streptococcus pneumoniae. J Infect Dis (1997) 1.74
American Academy of Pediatrics. Pediatric Practice Action Group and Task Force on Medical Informatics. Privacy protection and health information: patient rights and pediatrician responsibilities. Pediatrics (1999) 1.73
Viral polypeptides detected by a complement-dependent neutralizing murine monoclonal antibody to human cytomegalovirus. J Virol (1985) 1.73
Protein synthesis elongation factor EF-1 alpha is essential for ubiquitin-dependent degradation of certain N alpha-acetylated proteins and may be substituted for by the bacterial elongation factor EF-Tu. Proc Natl Acad Sci U S A (1994) 1.72
Determination of the number of endothelial cells in culture using an acid phosphatase assay. Anal Biochem (1986) 1.71
Vibrio parahaemolyticus gastroenteritis in Maryland. I. Clinical and epidemiologic aspects. Am J Epidemiol (1972) 1.70
Successful detection of small acoustic tumors using the stacked derived-band auditory brain stem response amplitude. Am J Otol (1997) 1.68
A comparison of electrical properties of neurons in Necturus retina. J Neurophysiol (1973) 1.57
The financially distressed hospital. N Engl J Med (1982) 1.56
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
A cohort study of stomach cancer risk in men after gastric surgery for benign disease. J Natl Cancer Inst (1993) 1.55
Viruses isolated from sheep. Nature (1969) 1.54
Coeliac disease in children of Asian immigrants. Lancet (1973) 1.54
Ser-Leu-Arg-Arg-atriopeptin III: the major circulating form of atrial peptide. Science (1985) 1.52
Amacrine cells, bipolar cells and ganglion cells of the cat retina: a Golgi study. Vision Res (1981) 1.50
Immunopharmacology: immunomodulation and immunotherapy. JAMA (1997) 1.50
Musculoskeletal dysfunction of the neck in migraine and tension headache. Headache (1994) 1.50
Single stage repair of the median cleft lip deformity in holoprosencephaly. J Craniomaxillofac Surg (1989) 1.48
Experimental assessment of small intestinal submucosa as a bladder wall substitute. Urology (1995) 1.46
Gut regulatory peptides and intestinal permeability in acute infantile gastroenteritis. Arch Dis Child (1992) 1.46
Family and peer issues among adolescents with spina bifida and cerebral palsy. Pediatrics (1991) 1.45
Structure of LEP100, a glycoprotein that shuttles between lysosomes and the plasma membrane, deduced from the nucleotide sequence of the encoding cDNA. J Cell Biol (1988) 1.44
A discordant sibship analysis between beta-NGF and neurofibromatosis. Am J Hum Genet (1985) 1.44
Anticoagulant-related intracranial haemorrhage. Br J Hosp Med (1993) 1.44
Regulating the bed supply in nursing homes. Milbank Mem Fund Q Health Soc (1980) 1.43
Human tissue factor: cDNA sequence and chromosome localization of the gene. Biochemistry (1987) 1.43
The significance of bcr-abl molecular detection in chronic myeloid leukemia patients "late," 18 months or more after transplantation. Blood (2001) 1.41
A spectrophotometric assay for neutral protease. Biochem Biophys Res Commun (1968) 1.40
Radioactive fallout in the United States due to the Fukushima nuclear plant accident. J Environ Monit (2012) 1.39
Effect of waterfowl (Anas platyrhynchos) on indicator bacteria populations in a recreational lake Madison, Wisconsin. Appl Environ Microbiol (1979) 1.38
Studies on the role of calcium in thermolysin. Biochemistry (1971) 1.38
Molecular cloning, sequence, and tissue distribution of the human ubiquitin-activating enzyme E1. Proc Natl Acad Sci U S A (1991) 1.38
Degradation of proteins with acetylated amino termini by the ubiquitin system. Science (1989) 1.37
Probiotics for treatment of Clostridium difficile-associated colitis in adults. Cochrane Database Syst Rev (2008) 1.35
Studies on the Bacillus subtilis neutral-protease- and Bacillus thermoproteolyticus thermolysin-catalyzed hydrolysis of dipeptide substrates. Biochemistry (1970) 1.35
Parasacrococcygeal approach for the resection of retrorectal developmental cysts. Dis Colon Rectum (1985) 1.34
Cell adhesion force microscopy. Proc Natl Acad Sci U S A (1999) 1.34
Search for neutrinoless double-beta decay in 136Xe with EXO-200. Phys Rev Lett (2012) 1.33
Poor people and poor hospitals: implications for public policy. J Health Polit Policy Law (1984) 1.32
Enzymatic activation of Fujinami sarcoma virus gag-fps transforming proteins by autophosphorylation at tyrosine. EMBO J (1987) 1.30
Inhibition of 2,4-dichlorophenoxyacetic Acid conjugation to amino acids by treatment of cultured soybean cells with cytokinins. Plant Physiol (1981) 1.28
A modified Farr assay is more specific than ELISA for measuring antibodies to Streptococcus pneumoniae capsular polysaccharides. J Infect Dis (1996) 1.27
Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy. Cancer J Sci Am (2006) 1.27
A comparison of 2,4-dichlorophenoxyacetic Acid metabolism in cultured soybean cells and in embryogenic carrot cells. Plant Physiol (1981) 1.26
Identification and morphological classification of horizontal, bipolar, and amacrine cells within the zebrafish retina. J Comp Neurol (2004) 1.26
A17: a broad-field amacrine cell in the rod system of the cat retina. J Neurophysiol (1985) 1.25
H-LA 1 and 8 in childhood coeliac disease. Lancet (1973) 1.24
The effect of pH on the rates of hydrolysis of three acylated dipeptides by pepsin. J Am Chem Soc (1968) 1.24
Milk feeding and changes in intestinal permeability and morphology in the newborn. J Pediatr Gastroenterol Nutr (1988) 1.24
An endoscopic evaluation of the effects of non-steroidal anti-inflammatory drugs on the gastric mucosa. Gastrointest Endosc (1975) 1.23
AII amacrine cells quicken time course of rod signals in the cat retina. J Neurophysiol (1982) 1.23
Duodenal ulceration: review of 110 cases. Arch Dis Child (1987) 1.23
Long-term care in the United States: an overview. Health Aff (Millwood) (2000) 1.23
Noninvasive evaluation of peripheral vascular disease using transcutaneous oxygen tension. Am J Surg (1982) 1.22
Large-scale purification of myeloperoxidase from HL60 promyelocytic cells: characterization and comparison to human neutrophil myeloperoxidase. Protein Expr Purif (2000) 1.22
Sequence of a bovine herpesvirus type-1 glycoprotein gene that is homologous to the herpes simplex gene for the glycoprotein gB. Virology (1988) 1.21
Purification and characterization of a novel species of ubiquitin-carrier protein, E2, that is involved in degradation of non-"N-end rule" protein substrates. J Biol Chem (1994) 1.21
Photon correlation spectroscopy of human IgG. J Protein Chem (1988) 1.21
Cryptosporidium parvum: in vitro cultivation in Madin-Darby canine kidney cells. J Protozool (1992) 1.20
OFF-alpha and OFF-beta ganglion cells in cat retina: II. Neural circuitry as revealed by electron microscopy of HRP stains. J Comp Neurol (1993) 1.20
Synaptic patterns and response properties of bipolar and ganglion cells in the cat retina. Vision Res (1983) 1.20